PVI
XENT

Pura Vida Investments’s Intersect ENT, Inc XENT Stock Holding History

Pura Vida Investments’s Portfolio XENT Stock Details XENT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-70,000
Closed -$2.62M – 146
2018
Q2 		$2.62M Buy
+70,000
New +$2.75M 1.05% 34

Other funds holding XENT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $9.84B AUM 190.63% 1-Year Est. Return
VI
Versor Investments New York $47.5M AUM 100.43% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
AAM
Alpine Associates Management Palm Beach, Florida $1.6B AUM 93.19% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Pura Vida Investments's XENT Position: Q3 2021 in Review

Pura Vida Investments sold out of Intersect ENT, Inc (XENT) in Q3 2021, closing a stake of 531,229 shares — an estimated $9.08M sold.

Pura Vida Investments first reported a position in XENT in Q4 2015 and held it in 21 quarters. The position peaked at $19.6M in Q4 2020. 123 funds tracked by Wall St. Rank hold XENT as of Q3 2021.

  • Pura Vida Investments reported no remaining Intersect ENT, Inc position as of Q3 2021 after selling out during the quarter.
  • Pura Vida Investments sold 531,229 Intersect ENT, Inc shares in Q3 2021, an estimated $9.08M.
  • Pura Vida Investments first reported a position in Intersect ENT, Inc in Q4 2015 and held it in 21 quarters.
  • Pura Vida Investments's Intersect ENT, Inc position peaked at $19.6M in Q4 2020.
  • 123 funds tracked by Wall St. Rank held Intersect ENT, Inc as of Q3 2021.

Based on Pura Vida Investments's 13F filing for Q3 2021, filed 15 Nov 2021.